[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
The efficacy of the use of moditen-depo and haloperidol decanoate as preventive anti-recurrence+ therapy was studied and compared in 2 groups of patients suffering from attack-like schizophrenia with frequent exacerbations. The cost-use analysis made it possible to establish their higher efficacy as compared to the routine maintenance therapy. Proceeding from the clinical, economic and socioeconomic indicators the use of haloperidol decanoate turned out more effective than the use of moditen-depo.
Ushakov
Iu V
IuV
Kravchenko
N E
NE
Kopeĭko
G I
GI
Kalugina
L I
LI
Mirzoian
M G
MG
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006220:Haloperidol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D012074:Remission Induction; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics
D014150:Antipsychotic Agents; C033563:haloperidol decanoate; C011825:fluphenazine depot; D006220:Haloperidol; D005476:Fluphenazine